This is what is happening, as told in this NYT article:
"... in light of recently released evidence that some drug makers have gone to great lengths to turn scientific articles into marketing vehicles for their products, some influential medical editors are cracking down on industry-financed ghostwriting. And they are getting help from some members of Congress.
"These editors are demanding that journals impose tougher disclosure policies for academic authors and that the journals enforce their own rules by actively investigating the provenance of manuscripts and by punishing authors who play down extensive contributions by ghostwriters."
These policies include retraction of the papers, and that “authors found to have not declared such interest should be banned from any subsequent publication in the journal and their misconduct reported to their institutions.”
That's all good and clear and hopefully they will actually implement these policies. But what about the medical writers that willingly ghostwrite articles at the request of pharmaceutical companies--sometimes slanting data? Should they be "punished" also? If so, how can we do that? And who would do it? AMWA? Congress?
Should ghostwriting be regulated in medical writing? What do you think?